NCT06431399

To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004

A Randomized, Open-label, Crossover Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004 in Healthy Adult Volunteers

• Status: Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (estimated)
• Sponsor: Jeil Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

To evaluate the safety, pharmacokinetic characteristics and the effect of food after administration of JLP-2004

Detailed description

A randomized, open-label, crossover phase 1 clinical trial to evaluate the safety, pharmacokinetic characteristics and the effect of food after administration of JLP-2004 in healthy adult volunteers

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	JLP-2004 qd	Group I(Peroid I-JLP-2004 FAST, Peroid II-JLP-2004 FED), Group II(Period I-JLP-2004 FED, Period II-JLP-2004 FAST)

Timeline

• Start date: 2024-04-23
• Primary completion: 2024-06-30
• Completion: 2024-07-12
• First posted: 2024-05-28
• Last updated: 2024-05-28

Locations

1 site across 1 country: South Korea